Comparative Study of the Efficacy of Induction Therapy with Cyclophosphamide or Mycophenolate Mofetil for Non-life-threatening Relapses of PR3- or MPO-ANCA Associated Vasculitis

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2004
The purpose of this study is to determine the efficacy and safety of a new drug, mycophenolate mofetil, for the treatment of relapses of ANCA-associated vasculitis (Wegener\'s granulomatosis or microscopic polyangiitis). Therefore, we compare the standard therapy with cyclophosphamide to mycophenolate mofetil. The investigators expect mycophenolate mofetil to be less toxic and almost equally effective as cyclophosphamide.
Epistemonikos ID: 4ad8161f724758650391e43cc6b93f916a2dc232
First added on: May 04, 2024